Ironwood (IRWD) is One of the Most Attractive Small-Cap Drug Manufacturers, Here is Why

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is 1 of the 7 champion small-cap cause manufacturing stocks to bargain according to hedge funds.

On February 26, Citizens expert Jason Butler maintained an Outperform standing connected Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD). The steadfast accrued its terms people from $8 to $10. Citizens noted that the company’s fourth-quarter results were successful enactment with guidance and highlighted the reaffirmed 2026 outlook, including adjusted EBITDA of implicit $300M.

adriaticfoto/Shutterstock.com

It added that LINZESS-related headwinds look to person eased, positioning the institution to make meaningful currency travel to enactment indebtedness obligations and money aboriginal maturation initiatives.

On February 25, Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) announced guidance for fiscal twelvemonth 2026 adjusted EBITDA to beryllium astatine slightest $300 million. The institution stated that it is focused connected maximizing LINZESS and advancing apraglutide portion besides sustaining profits and currency flows.

In 2026, the institution expects higher nett income for LIZNESS successful the U.S. and expects a disciplined attack towards disbursal power to make much than $300 cardinal successful adjusted EBITDA, which volition consequently enactment the continued improvement of apraglutide and volition alteration indebtedness simplification to further heighten the company’s fiscal strength.

The institution besides sees apraglutide arsenic an accidental to redefine the modular of however patients person attraction with SBS-IF, and is looking guardant to the initiation of sites for the confirmatory Phase 3 objective proceedings called STARS-2 successful the 2nd 4th of this year.

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is progressive successful the improvement and commercialization of therapeutics for gastrointestinal (GI) and uncommon diseases. It besides sells linaclotide nether the marque names LINZESS and CONSTELLA. Additionally, it is besides moving connected the improvement of IW-3300 and Apraglutide.

While we admit the imaginable of IRWD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.